GN Store Nord Debt to Equity Ratio 2016-2024 | GNNDY

Current and historical debt to equity ratio values for GN Store Nord (GNNDY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GN Store Nord debt/equity for the three months ending December 31, 2024 was 0.83.
GN Store Nord Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $2.87B $1.57B 1.83
2024-09-30 $2.86B $1.50B 1.90
2024-06-30 $2.82B $1.47B 1.92
2024-03-31 $2.83B $1.45B 1.95
2023-12-31 $3.06B $1.39B 2.20
2023-09-30 $3.11B $1.42B 2.20
2023-06-30 $3.06B $1.36B 2.26
2023-03-31 $3.35B $0.96B 3.51
2022-12-31 $3.37B $0.96B 3.50
2022-09-30 $3.23B $0.97B 3.32
2022-06-30 $3.26B $0.95B 3.43
2022-03-31 $3.24B $0.91B 3.57
2021-12-31 $2.76B $0.99B 2.78
2021-09-30 $1.89B $0.91B 2.07
2021-06-30 $1.86B $0.95B 1.95
2021-03-31 $1.85B $0.96B 1.93
2020-12-31 $1.76B $0.79B 2.22
2020-09-30 $1.83B $0.77B 2.39
2020-06-30 $1.64B $0.67B 2.47
2020-03-31 $1.60B $0.68B 2.36
2019-12-31 $1.77B $0.73B 2.44
2019-09-30 $1.50B $0.70B 2.14
2019-06-30 $1.47B $0.67B 2.18
2019-03-31 $1.40B $0.74B 1.89
2018-12-31 $1.26B $0.81B 1.55
2018-09-30 $1.21B $0.74B 1.63
2018-06-30 $1.18B $0.75B 1.58
2018-03-31 $1.09B $0.68B 1.60
2017-12-31 $1.06B $0.73B 1.45
2017-09-30 $1.05B $0.75B 1.40
2017-06-30 $0.97B $0.72B 1.35
2017-03-31 $0.95B $0.73B 1.31
2016-12-31 $1.07B $0.84B 1.28
2016-09-30 $0.97B $0.82B 1.19
2016-06-30 $0.86B $0.82B 1.06
2016-03-31 $0.83B $0.78B 1.06
2015-12-31 $0.81B $0.86B 0.94
2015-09-30 $0.00B 0.00
2015-06-30 $0.00B 0.00
2015-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $2.068B $2.609B
GN Store Nord A/S offers medical hearing instruments, professional and consumer headsets. The Company's operating segments include GN Netcom, GN ReSound and Others. GN Netcom segment sells hands-free communications solutions in the form of headsets for mobile phones and traditional phones. GN ReSound segment operates within the hearing instrument industry, and produces and sells hearing healthcare instruments and related products. It offers hearing aids and accessories under the ReSound, Beltone and Interton brand names. GN Store Nord A/S is based in Ballerup, Denmark.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $231.085B 27.79
Boston Scientific (BSX) US $155.238B 38.86
Stryker (SYK) US $144.362B 30.18
EssilorLuxottica (ESLOY) FR $132.860B 0.00
Medtronic (MDT) IE $108.824B 15.89
Lonza Group Ag (LZAGY) CH $52.624B 0.00
Haleon (HLN) GB $48.259B 27.44
ResMed (RMD) US $35.183B 26.43
GE HealthCare Technologies (GEHC) US $32.295B 15.33
Agilent Technologies (A) US $30.971B 20.46
Terumo (TRUMY) JP $29.019B 0.00
Koninklijke Philips (PHG) NL $24.053B 17.17
Zimmer Biomet Holdings (ZBH) US $20.255B 12.80
Insulet (PODD) US $18.084B 77.18
Baxter (BAX) US $15.752B 11.77
Smith & Nephew SNATS (SNN) GB $12.535B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.970B 0.00
Lantheus Holdings (LNTH) US $7.447B 18.31
Bio-Rad Laboratories (BIO) US $6.620B 22.38
Prestige Consumer Healthcare (PBH) US $4.171B 19.90
Perrigo (PRGO) IE $3.497B 10.01
ICU Medical (ICUI) US $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Haemonetics (HAE) US $3.208B 15.10
Envista Holdings (NVST) US $2.880B 23.93
QuidelOrtho (QDEL) US $1.964B 16.45
LeMaitre Vascular (LMAT) US $1.778B 39.75
AtriCure (ATRC) US $1.486B 0.00
Green Thumb Industries (GTBIF) US $1.374B 21.63
Neogen (NEOG) US $1.248B 15.97
Kestra Medical Technologies (KMTS) US $1.220B 0.00
BioLife Solutions (BLFS) US $1.200B 0.00
AdaptHealth (AHCO) US $1.184B 11.40
InMode (INMD) IL $1.013B 9.28
Phibro Animal Health (PAHC) US $0.789B 12.10
Evolus (EOLS) US $0.779B 0.00
Curaleaf Holdings (CURLF) CA $0.637B 0.00
CeriBell (CBLL) US $0.588B 0.00
Owens & Minor (OMI) US $0.580B 4.94
Valneva SE (VALN) FR $0.549B 0.00
Capricor Therapeutics (CAPR) US $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.526B 0.00
Tilray Brands (TLRY) CA $0.458B 0.00
Cresco Labs (CRLBF) US $0.442B 0.00
Omeros (OMER) US $0.418B 0.00
Surmodics (SRDX) US $0.395B 0.00
SNDL (SNDL) CA $0.365B 0.00
VAREX IMAGING (VREX) US $0.359B 15.55
SEMPERIT AG HLD (SEIGY) AT $0.317B 0.00
Verano Holdings (VRNOF) US $0.296B 0.00
Sanara MedTech (SMTI) US $0.292B 0.00
Viemed Healthcare (VMD) US $0.291B 26.32
Aurora Cannabis (ACB) CA $0.272B 48.40
Sanuwave Health (SNWV) US $0.264B 0.00
ZimVie (ZIMV) US $0.261B 15.60
Cerus (CERS) US $0.258B 0.00
Canopy Growth (CGC) CA $0.245B 0.00
Quanterix (QTRX) US $0.233B 0.00
OraSure Technologies (OSUR) US $0.231B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.190B 4.35
Utah Medical Products (UTMD) US $0.173B 13.93
Brainsway (BWAY) IL $0.170B 53.06
TriSalus Life Sciences (TLSI) US $0.165B 0.00
Organigram Global (OGI) CA $0.154B 0.00
FitLife Brands (FTLF) US $0.148B 18.22
Jin Medical (ZJYL) CN $0.119B 0.00
TerrAscend (TSNDF) CA $0.116B 0.00
MacroGenics (MGNX) US $0.110B 0.00
Exagen (XGN) US $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) US $0.095B 0.00
Quipt Home Medical (QIPT) US $0.094B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
Veru (VERU) US $0.075B 0.00
InterCure (INCR) IL $0.073B 0.00
Zynex (ZYXI) US $0.070B 0.00
United Health Products (UEEC) US $0.064B 0.00
Cytosorbents (CTSO) US $0.059B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Apyx Medical (APYX) US $0.047B 0.00
Modular Medical (MODD) US $0.042B 0.00
Rockwell Medical (RMTI) US $0.042B 61.50
United-Guardian (UG) US $0.037B 11.28
Safety Shot (SHOT) US $0.036B 0.00
Nephros (NEPH) US $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.015B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00